Hims & Hers Health (HIMS) Undisclosed Privacy/Billing Practices Case

Investors can submit applications for the lead plaintiff role.

N.D. California

Court

3:26-cv-09313

Case number

08/04/2025

Class period Start

07/29/2026

Class period End

11/02/2026

Lead Plaintiff motion deadline

$HIMS investors filed a claim against Hims & Hers Health, Inc. for touting robust privacy safeguards and transparent billing practices in its SEC filings, while failing to disclose that the Company shared consumers' sensitive health information with third-party advertisers like Meta and Snap and charged consumers for prescriptions almost immediately after intake, without the promised provider consultation.
After the FTC announced a lawsuit alleging Hims engaged in deceptive and unlawful privacy practices — including sharing health information with third-party ad platforms and misleading consumers about billing and cancellation — Hims' stock fell 14.73% on July 29, 2026.
$HIMS investors can join this case to be notified about potential recovery.
Case Details:

Hims & Hers Health operates a health and wellness platform connecting consumers to licensed healthcare providers, offering prescription and non-prescription products through its website and app. Throughout the Class Period, in quarterly and annual SEC filings beginning August 4, 2025, Hims represented that it had "developed and maintain[ed] policies and procedures" — including administrative, physical, and technical safeguards — to protect users' private health information, while disclosing only generic, hypothetical risks tied to personally identifiable information handling. 

The Company also referenced an ongoing, non-public FTC Civil Investigative Demand from October 2023 regarding its privacy, advertising, and cancellation practices, characterizing the matter as unlikely to have a material impact, and by May 2026 had accrued only $15 million for the matter while stating settlement negotiations were underway.

These statements omitted material facts: Hims shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap; the Company charged consumers for prescriptions almost immediately after intake form submission despite promising a provider consultation to find a treatment "right for them"; and this conduct had subjected the Company to regulatory scrutiny likely to result in fees and penalties.

On July 29, 2026, the FTC announced it had sued Hims, joined by Utah and California, alleging the Company shared consumers' sensitive health information with at least a dozen third-party advertising platforms (including Meta, Snap, Google, TikTok, Pinterest, and others) via tracking pixels, despite promising a "100% online, private, and secure" platform, and that it deceived consumers by charging them for prescriptions immediately after intake without the promised medical consultation, while making cancellation difficult. 

On this news, Hims stock fell $4.32 (14.73%) to close at $25.00 on unusually heavy trading volume.

Based on these events, $HIMS investors filed a claim against Hims & Hers Health, Inc., alleging the company:
Misrepresented the strength and adequacy of its privacy safeguards for consumer health information
Failed to disclose that it shared sensitive health data with third-party advertising platforms
Failed to disclose that it charged consumers for prescriptions without the promised provider consultation
Investors argue that had the truth about Hims' privacy and billing practices been disclosed earlier, the Company's stock would not have traded at artificially inflated prices during the Class Period.

Case Type

US Securities Class Action

Case Status

Lead Plaintiff Submission

Alleged Offence

Misleading Statements,

Failure to Disclose

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

07/29/2026

Filing date

09/01/2026

Lead Plaintiff Deadline

11/02/2026